Top Qs
Timeline
Chat
Perspective
Nemtabrutinib
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Nemtabrutinib (MK-1026, formerly ARQ 531) is a small molecule drug that works as a reversible Bruton's tyrosine kinase (BTK) inhibitor; unlike other BTK inhibitors it also works against some mutated forms of BTK.[1][2][3][4][5] Merck paid $2.7 billion to acquire the company ArQule and the drug, which is being investigated as a cancer treatment.[6]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads